MABRON INJECTION 100 mg/2 ml
Product details
Registration number: SIN08740P
Classification: Prescription Only
Active ingredients: TRAMADOL 88 MG/ 2ML EQV TRAMADOL HCl
Strength: 100 mg/2 ml
Dosage form: INJECTION
Route: INTRAVENOUS; SUBCUTANEOUS; INTRAMUSCULAR
Registrant: MEDOCHEMIE SINGAPORE PTE. LTD.
ATC code: N02AX02
HSA approval date: 6 June 1996
Manufacturer(s): Medochemie Ltd – Facility Ampoules Inj.
Manufacturing country/countries: CYPRUS
What are the HSA registration number and classification for MABRON INJECTION 100 mg/2 ml?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN08740P
Classification: Prescription Only
What active ingredients and strength are recorded for MABRON INJECTION 100 mg/2 ml?
According to the HSA dataset updated 7 August 2026:
Active ingredients: TRAMADOL 88 MG/ 2ML EQV TRAMADOL HCl
Strength: 100 mg/2 ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for MABRON INJECTION 100 mg/2 ml?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION
Route: INTRAVENOUS; SUBCUTANEOUS; INTRAMUSCULAR
Who is the recorded registrant for MABRON INJECTION 100 mg/2 ml?
According to the HSA dataset updated 7 August 2026:
Registrant: MEDOCHEMIE SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for MABRON INJECTION 100 mg/2 ml?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Medochemie Ltd – Facility Ampoules Inj.
Manufacturing country/countries: CYPRUS
Where can I look up MABRON INJECTION 100 mg/2 ml in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN08740P or the exact product name MABRON INJECTION 100 mg/2 ml. The general register link does not preselect this product.
What are the source dates for this MABRON INJECTION 100 mg/2 ml record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this MABRON INJECTION 100 mg/2 ml record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN08740P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)